# ApoB48 Metabolism in Plasma and Interstitial Fluid

> **NCT03921203** · — · COMPLETED · sponsor: **Karolinska University Hospital** · enrollment: 22 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03921203
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-17
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-12-31
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03921203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03921203, "ApoB48 Metabolism in Plasma and Interstitial Fluid". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03921203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*